KLK1 and pulmonary arterial hypertension: Nonetheless, this gene and pathway offer potential therapeutic targets, having major functions in areas of dysfunction seen in PAH, demonstrated by the evidence showing that KLK1 can be used for its vasodilative properties in the treatment of acute ischemic stroke [272].